United States · Venture startup
5 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$47Mraised across 5 rounds since 2005, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by finsmes.comSEC filing: $15M sold, first sale Feb 2012
Reported by sec.govSEC filing: $7.0M sold, first sale Dec 2010
No investor was named in the report.
From a historical funding recordSEC filing: $315K sold, first sale Mar 2010
Reported by satoripharma.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
New Enterprise Associates
InterWest Partners
Prospect Venture Partners
PureTech HealthMissing a round, or an investor who was in one? Tell us.
Satori Pharmaceuticals's investors include New Enterprise Associates, InterWest Partners, Prospect Venture Partners and PureTech Health.
Satori Pharmaceuticals has raised $47M across 5 rounds since 2005.
Satori Pharmaceuticals's most recent round was a Venture of $15M in Feb 2012.
Satori Pharmaceuticals's largest round on record is $22M (Series A), in Jan 2009.
Satori Pharmaceuticals's first round on record, in Jan 2005, was backed by PureTech Health.
Satori Pharmaceuticals's latest named round is a Venture, in Feb 2012.
Satori Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·